Discontinuation and reinitiation of SGLT-2 inhibitors and GLP-1R agonists in patients with type 2 diabetes: a nationwide study from 2013 to 2021

BACKGROUND: Small observational studies have observed poor persistency to sodium-glucose cotransporter-2 inhibitors (SGLT2-i) and glucacon-like-peptide-1-receptor agonists (GLP1-RA), contrary to what has been reported in clinical trials. Therefore, we investigated the risk of discontinuing SGLT2-is...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Mariam Elmegaard, Falkentoft, Alexander Christian, Jensen, Jesper, Zahir, Deewa, Parveen, Saaima, Alhakak, Amna, Andersson, Charlotte, Petrie, Mark C., Sattar, Naveed, McMurray, John J.V., Køber, Lars, Schou, Morten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230617/
https://www.ncbi.nlm.nih.gov/pubmed/37265783
http://dx.doi.org/10.1016/j.lanepe.2023.100617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230617/
https://www.ncbi.nlm.nih.gov/pubmed/37265783
http://dx.doi.org/10.1016/j.lanepe.2023.100617

Ejemplares similares